CLINICAL_TRIALS
trial_result
· 2018-06-25
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention [Phase 3]
Summary
Phase 3 trial evaluating erenumab (AMG 334) versus placebo for migraine prevention has completed with posted results in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2018-06-25